Growth hormone (GH) replacement therapy: Cancer in adults treated with GH

Growth Hormone and IGF Research

Volumn 10, Issue SUPPL. A, 2000, Pages

  Monson, J P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ACROMEGALY; BRAIN TUMOR; CANCER; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL TUMOR; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LARYNX CARCINOMA; LUNG CARCINOMA; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; SKIN CANCER; UTERUS CANCER;

EID: 0033873769     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(00)90025-X     Document Type: Conference Paper

References (8)

1. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: A dose-finding study
2. Growth hormone deficiency and replacement in elderly hypopituitary adults
3. Premature mortality due to cardiovascular disease in hypopituitarism
4. Mortality and cancer incidence in acromegaly: A retrospective cohort study
5. Acromegaly, colonic polyps and neoplasia
6. Effect of growth hormone (GH) and insulin-like growth factor-I on prostate diseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects
7. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
8. Insulin-like growth factor-I and prostate cancer risk: A population-based, case control study